A child with severe haemophilia was regularly treated at Alder Hey with concentrate, "at least some of it commercial after mid-1983." Read more about A child with severe haemophilia was regularly treated at Alder Hey with concentrate, "at least some of it commercial after mid-1983."
Information from legal claims relating to other children treated at Alder Hey reveal the appropriate approach to treatment. Read more about Information from legal claims relating to other children treated at Alder Hey reveal the appropriate approach to treatment.
Other documentation arising in the context of litigation suggests that "no specific priority was given to mild haemophiliacs for treatment with NHS product at the time." Read more about Other documentation arising in the context of litigation suggests that "no specific priority was given to mild haemophiliacs for treatment with NHS product at the time."
When Professor Hay arrived in Liverpool he found records to be poor and uninformative and was unable to obtain the results of the tests that had been carried out. He was told by patients that they were informed of HIV positive results by letter. Read more about When Professor Hay arrived in Liverpool he found records to be poor and uninformative and was unable to obtain the results of the tests that had been carried out. He was told by patients that they were informed of HIV positive results by letter.
Professor Hay stated that "all patients were treated with whichever material was available. No cohorts were treated with any specific product". He stated insufficient use of cryoprecipitate was used. Read more about Professor Hay stated that "all patients were treated with whichever material was available. No cohorts were treated with any specific product". He stated insufficient use of cryoprecipitate was used.
The purchase of commercial Factor 8 concentrates was undertaken via the Royal Liverpool Hospital, in part because the district health authority was able to get a better price per unit by buying in bulk, and supplied by the Royal Liverpool's haemophilia ward to Alder Hey. Read more about The purchase of commercial Factor 8 concentrates was undertaken via the Royal Liverpool Hospital, in part because the district health authority was able to get a better price per unit by buying in bulk, and supplied by the Royal Liverpool's haemophilia ward to Alder Hey.
Dr McVerry stated he "was encouraged to switch to commercial F8 for two reasons". Availability and reliability of supply, and the general policy to keep an individual patient on one specific product to reduce prevalence of factor antibodies arising Read more about Dr McVerry stated he "was encouraged to switch to commercial F8 for two reasons". Availability and reliability of supply, and the general policy to keep an individual patient on one specific product to reduce prevalence of factor antibodies arising
Dr McVerry could not recall giving cryoprecipitate to a patient in Liverpool. Read more about Dr McVerry could not recall giving cryoprecipitate to a patient in Liverpool.
Dr McVerry indicated that he had no awareness of AIDS until the September 1982 UKHCDO meeting. Up to mid 1984, there was no proven association with blood products, although he said it was reasonably clear there was a real risk at the end of 1983 or beginning of 1984. Read more about Dr McVerry indicated that he had no awareness of AIDS until the September 1982 UKHCDO meeting. Up to mid 1984, there was no proven association with blood products, although he said it was reasonably clear there was a real risk at the end of 1983 or beginning of 1984.
In Liverpool, the use of NHS concentrate increased in 1984. Read more about In Liverpool, the use of NHS concentrate increased in 1984.